Dexamethasone plus oseltamivir versus dexamethasone in treatment-naive primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial

Study (n=120) found those given oseltamivir 75mg bd for 10 days plus dexamethasone 40mg daily for 4 days had a higher response rate (platelets >100) vs dexamethasone alone by day 14 (86% vs 66%, OR 3.18, p=0.03). Authors conclude this combination warrants further investigation.

The Lancet Haematology